Sandbox/table

The following table contains the main risk factors for CDI:^[1]^[2]^[3]^[2]^[2]

Alterations in the coagulation system
Consumption of clotting factors
Increased concentrations of fibrin degradation products
Disseminated intravascular coagulation

table

**Ebola virus strains identified**
Ebola virus strain	Place of discovery	Date
Sudan ebolavirus	Sudan	Between June and November 1976
Zaire ebolavirus	Yambuku, Democratic Republic of the Congo (formerly Zaire)	Between August and November 1976
Reston ebolavirus	Reston, Virginia, US.	November 1989
Ivory Coast ebolavirus	Tai Forest, Cote d'Ivoire.	November 1994
Bundibugyo ebolavirus	Bundibugyo District, Uganda	November 2007

**Countries with a reported prevalence <15% of *H. pylori* resistance to clarithromycin**
Diagnostic test	North America	South America	Middle East	Far East
ELISA (serology) detects: Viral Antigen IgM and IgG antibody \| hol

^† There is a reported prevalence of 15% in the Northeast of the US.

↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
↑ ^2.0 ^2.1 ^2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.